Interbody fusion with allograft and rhBMP-2 leads to consistent fusion but early subsidence

Journal of Bone and Joint Surgery - Series B

Volumn 89, Issue 3, 2007, Pages 342-345

  Vaidya, R ^a   Weir, R ^b   Sethi, A ^a   Meisterling, S ^b   Hakeos, W ^b   Wybo, C D ^b  

^a DETROIT RECEIVING HOSPITAL   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN SPONGE; INFUSE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ALLOGRAFT; ARTICLE; BONE EROSION; BONE MATRIX; BONE PAIN; BONE SWELLING; CERVICAL MYELOPATHY; CERVICAL SPINE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPHAGIA; FEMALE; FOLLOW UP; GRAFT DYSFUNCTION; HUMAN; INTERVERTEBRAL DISK HERNIA; INTERVERTEBRAL DISKECTOMY; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MYALGIA; ORTHOPEDIC SURGERY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDARTHROSIS; RETREATMENT; SCOLIOSIS; SPINE FUSION; SPINE RADIOGRAPHY; SPONDYLOLISTHESIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BONE MATRIX; BONE MORPHOGENETIC PROTEINS; BONE TRANSPLANTATION; CERVICAL VERTEBRAE; FEMALE; HUMANS; INTERVERTEBRAL DISK DISPLACEMENT; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; PAIN MEASUREMENT; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; REOPERATION; SCOLIOSIS; SPINAL CORD DISEASES; SPINAL FUSION; SPONDYLOLISTHESIS; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME;

EID: 34147186878     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.89B3.18270     Document Type: Article

References (22)

1. Hidehiro I, Sohei E, Mikio K, et al. Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2. Spine 1999;24:1402-5.
2. Schimandle J, Boden SD, Hutton WC. Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine 1995;20:1326-37.
3. Mummaneni PV, Pan J, Haid RW, Rodts GE. Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. J Neurosurg Spine 2004;1:19-23.
4. Boden SD, Kang J, Sandhu H, Heller JG. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial. Spine 2002;27:2662-73.
5. Burkus JK, Heim SE, Gornet MF, Zdeblick TA. The effectiveness of rhBMP-2 in replacing autograft: an integrated analysis of three human spine studies. Orthopedics 2004;27:723-8.
6. Burkus JK. Bone morphogenetic proteins in anterior lumbar interbody fusion: old techniques and new technologies. J Neurosurg Spine 2004;3:254-60.
7. Poynton AR, Lane JM. Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine 2002:27(Suppl 4):40-8.
8. Boakye M, Mummaneni PV, Garrett M, Rodts G, Haid R. Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein. J Neurosurg Spine 2005;2:521-5.
9. Murnaghan M, McIlmurray L, Mushipe MT, Li G. Time for treating bone fracture using rhBMP-2: a randomized placebo controlled mouse fracture trial. J Orthop Res 2005;23:625-31.
10. Zhang H, Sucato DJ, Welch RD. Recombinant human bone morphogenetic protein-2-enhanced anterior spine fusion without bone encroachment into the spinal canal: a histomorphometric study in a thorascopically instrumented porcine model. Spine 2005;30:512-18.
11. No authors listed. Food and Drug Agency. http://www.fda.gov/ cdrh/pdf/P000058.html. (date last accessed 2 July 2002).
12. Sandu HS, Khan SN. Recombinant human bone morphogenetic protein-2: use in spinal fusion applications. J Bone Joint Surg [Am] 2003;85-A(Suppl 3):89-95.
13. Burkus JK, Transfeldt EE, Kitchel SH, Watskins RG, Balderston RA. Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine 2002;27:2396-408.
14. Janssen ME, Lam C, Beckham R. Outcomes of allogenic cages in anterior and posterior lumbar interbody fusion. Eur Spine J 2001;10(Suppl 2):158-68.
15. Fairbank JC, Crouper J, Davies JB, O'Brien JP. The Oswestry low back disability questionnaire. Physiotherapy 1980;66:271-3.
16. Chapman CR, Case KL, Dubner R, et al. Pain measurement: an overview. Pain 1985;22:1-31.
17. Kaneko H, Arakawa T, Mano H, et al. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. Bone 2000;27:479-86.
18. Fukui N, Zhu Y, Maloney JW, Clohisy J, Sandell LJ. Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-α in normal and osteoarthritic chondrocytes. J Bone Joint Surg [Am] 2003;85-A(Suppl 3):59-66.
19. Merrihew C, Soeder S, Rueger DC, Kuettner KE, Chubinskaya S. Modulation of endogenous osteogenic protein-1 (OP-1) by interleukin-1 in adult human articular cartilage. J Bone Joint Surg [Am] 2003;85-A(Suppl 3):67-74.
20. Udagawa N. Mechanisms involved in bone resorption. Biogerontology 2002;3:79-83.
21. Otsuka E, Notoya M, Hagiwara H. Treatment of myoblastic C2C12 cells with BMP-2 stimulates vitamin D-induced formation of osteoclasts. Calcif Tissue Int 2003;73:72-7.
22. Burkus JK, Sandhu HS, Gornett MF, Longley MC. Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery. J Bone Joint Surg [Am] 2005;87-A:1205-12.